Concentrix Corp Files Quarterly Report on Form 10-Q
Ticker: CNXC · Form: 10-Q · Filed: Apr 3, 2026 · CIK: 0001803599
| Field | Detail |
|---|---|
| Company | Concentrix CORP (CNXC) |
| Form Type | 10-Q |
| Filed Date | Apr 3, 2026 |
| Risk Level | low |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: Concentrix Corp, CNXC, 10-Q, SEC Filing, Quarterly Report
TL;DR
<b>Concentrix Corp has filed its quarterly report (Form 10-Q) for the period ending February 28, 2026.</b>
AI Summary
Concentrix Corp (CNXC) filed a Quarterly Report (10-Q) with the SEC on April 3, 2026. Filing Date: 2026-04-03. Period of Report: 2026-02-28. Document Type: 10-Q. SEC Accession No.: 0001803599-26-000122. Company CIK: 0001803599.
Why It Matters
For investors and stakeholders tracking Concentrix Corp, this filing contains several important signals. This filing provides an update on Concentrix Corp's financial performance and operational status for the most recent fiscal quarter. Investors and analysts can use this report to assess the company's financial health, identify trends, and make informed investment decisions.
Risk Assessment
Risk Level: low — Concentrix Corp shows low risk based on this filing. The filing is a routine quarterly report and does not contain any immediate red flags or significant new information that would suggest a high-risk event.
Analyst Insight
Monitor future filings for detailed financial results and management commentary to understand performance trends.
Key Numbers
- 2026-04-03 — Filing Date (SEC Filing)
- 2026-02-28 — Period of Report (SEC Filing)
- 10-Q — Document Type (SEC Filing)
- 0001803599-26-000122 — SEC Accession No. (SEC Filing)
Key Players & Entities
- Concentrix Corp (company) — Filer
- 0001803599-26-000122 (other) — SEC Accession No.
- 2026-04-03 (date) — Filing Date
- 2026-02-28 (date) — Period of Report
- 0001803599 (other) — CIK
FAQ
When did Concentrix Corp file this 10-Q?
Concentrix Corp filed this Quarterly Report (10-Q) with the SEC on April 3, 2026.
What is a 10-Q filing?
A 10-Q is a quarterly financial report with unaudited financials, management discussion, and interim business updates. This particular 10-Q was filed by Concentrix Corp (CNXC).
Where can I read the original 10-Q filing from Concentrix Corp?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Concentrix Corp.
What are the key takeaways from Concentrix Corp's 10-Q?
Concentrix Corp filed this 10-Q on April 3, 2026. Key takeaways: Filing Date: 2026-04-03. Period of Report: 2026-02-28. Document Type: 10-Q.
Is Concentrix Corp a risky investment based on this filing?
Based on this 10-Q, Concentrix Corp presents a relatively low-risk profile. The filing is a routine quarterly report and does not contain any immediate red flags or significant new information that would suggest a high-risk event.
What should investors do after reading Concentrix Corp's 10-Q?
Monitor future filings for detailed financial results and management commentary to understand performance trends. The overall sentiment from this filing is neutral.
How does Concentrix Corp compare to its industry peers?
Concentrix Corp operates in the business services sector, providing a range of customer engagement and business process outsourcing solutions.
Are there regulatory concerns for Concentrix Corp?
The filing is made in accordance with SEC regulations for quarterly reporting by public companies.
Industry Context
Concentrix Corp operates in the business services sector, providing a range of customer engagement and business process outsourcing solutions.
Regulatory Implications
The filing is made in accordance with SEC regulations for quarterly reporting by public companies.
What Investors Should Do
- Review the full 10-Q document for detailed financial statements and disclosures.
- Analyze the company's performance against industry benchmarks.
- Track any management commentary or forward-looking statements within the report.
Key Dates
- 2026-04-03: Filing Date — Submission of the quarterly report to the SEC.
- 2026-02-28: Period of Report End Date — The end of the fiscal quarter for which the report is filed.
Year-Over-Year Comparison
This is a standard quarterly filing (10-Q) and does not represent a change from previous filing types.
Filing Stats: 4,457 words · 18 min read · ~15 pages · Grade level 20 · Accepted 2026-04-03 08:22:03
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share CNXC The Nasdaq Stock Marke
Filing Documents
- cnxc-20260228.htm (10-Q) — 1316KB
- exhibit311-form10qxq12026.htm (EX-31.1) — 10KB
- exhibit312-form10qxq12026.htm (EX-31.2) — 10KB
- exhibit321-form10qxq12026.htm (EX-32.1) — 6KB
- cnxc-20260228_g1.jpg (GRAPHIC) — 57KB
- 0001803599-26-000122.txt ( ) — 7904KB
- cnxc-20260228.xsd (EX-101.SCH) — 43KB
- cnxc-20260228_cal.xml (EX-101.CAL) — 80KB
- cnxc-20260228_def.xml (EX-101.DEF) — 236KB
- cnxc-20260228_lab.xml (EX-101.LAB) — 625KB
- cnxc-20260228_pre.xml (EX-101.PRE) — 476KB
- cnxc-20260228_htm.xml (XML) — 1156KB
Financial Statements
Financial Statements 2 Consolidated Balance Sheets as of February 28, 2026 (unaudited) and November 30, 2025 2 Consolidated Statements of Operations (unaudited) for the Three Months Ended February 28, 2026 and 2025 3 Consolidated Statements of Comprehensive Income (unaudited) for the Three Months Ended February 28, 2026 and 2025 4 Consolidated Statements of Stockholders' Equity (unaudited) for the Three Months Ended February 28, 2026 and 2025 5 Consolidated Statements of Cash Flows (unaudited) for the Three Months Ended February 28, 2026 and 2025 6 Notes to the Consolidated Financial Statements (unaudited) 7 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 27 Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 41 Item 4.
Controls and Procedures
Controls and Procedures 42 PART II OTHER INFORMATION 43 Item 1.
Legal Proceedings
Legal Proceedings 43 Item 1A.
Risk Factors
Risk Factors 43 Item 2. Unregistered S ales of E quity S ecurities and U se of P roceeds 43 Item 5. Other Information 43 Item 6. Exhibits 44
—FINANCIAL INFORMATION
PART I—FINANCIAL INFORMATION
FINANCIAL STATEMENTS
ITEM 1. FINANCIAL STATEMENTS CONCENTRIX CORPORATION CONSOLIDATED BALANCE SHEETS (currency and share amounts in thousands, except par value) February 28, 2026 November 30, 2025 (unaudited) ASSETS Current assets: Cash and cash equivalents $ 222,699 $ 327,347 Accounts receivable, net 2,038,296 1,999,021 Assets held for sale 207,502 — Other current assets 572,718 758,135 Total current assets 3,041,215 3,084,503 Property and equipment, net 726,063 735,550 Goodwill 3,696,052 3,671,746 Intangible assets, net 1,867,038 1,960,338 Deferred tax assets 314,044 317,453 Other assets 1,030,210 991,496 Total assets $ 10,674,622 $ 10,761,086 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 202,424 $ 244,771 Current portion of long-term debt 750,000 65,625 Accrued compensation and benefits 622,039 764,962 Other accrued liabilities 736,782 997,198 Income taxes payable 89,147 123,794 Liabilities held for sale 174,941 — Total current liabilities 2,575,333 2,196,350 Long-term debt, net 3,995,253 4,572,889 Other long-term liabilities 1,014,676 950,983 Deferred tax liabilities 300,946 296,519 Total liabilities 7,886,208 8,016,741 Commitments and contingencies (Note 14) Stockholders' equity: Preferred stock, $ 0.0001 par value, 10,000 shares authorized and no shares issued and outstanding as of February 28, 2026 and November 30, 2025, respectively — — Common stock, $ 0.0001 par value, 250,000 shares authorized; 70,546 and 70,316 shares issued as of February 28, 2026 and November 30, 2025, respectively, and 60,822 and 61,739 shares outstanding as of February 28, 2026 and November 30, 2025, respectively 7 7 Additional paid-in capital 3,814,078 3,783,972 Treasury stock, 9,724 and 8,577 shares as of February 28, 2026 and November 30, 2025, respectively ( 656,047 ) ( 610,162 ) Retained deficit ( 178,645 ) ( 1